Two good.

Pfizer announced yesterday that it’s two-dose vaccine has proven to effectively reduce COVID-19 cases by 90% at interim analysis of its massive phase 3 trial after just 94 of a planned 164 events , with a submission for emergency authorization by the FDA anticipated to occur by Thanksgiving. | Pfizer 2020